The ovarian reserve experiences a gradual decline from birth, but the drop accelerates significantly around the age of 35. The same age does not guarantee the same number of follicles, even among healthy women, which complicates any individual prediction.
Some genetic variations or pathologies go unnoticed until difficulties in conceiving arise. Current assessment methods provide indications without offering absolute certainty about future fertility.
You may also like : Transform Your Living Room with a Sectional Sofa: Spacious Elegance at the Heart of Your Home
Understanding ovarian reserve at 35: what are we really talking about?
The follicular reserve, as one approaches their forties, becomes a serious concern for many women and the professionals who support them. From birth, the stock of ovarian follicles is set: each woman inherits a unique capital, which decreases steadily over the years. This capital directly influences fertility and the ovaries’ ability to produce quality oocytes.
By the age of 35, the rate of follicular loss intensifies. The number of follicles at 35 then becomes a closely monitored indicator: it guides medical strategies and sometimes directs towards assisted reproductive technology. The evaluation relies on antral follicle count, performed at the beginning of the cycle via ultrasound. This number gives an idea of the ovaries’ potential response to hormonal stimulation.
Further reading : Choosing the Ideal Fire Pit: Heat at the Heart of Your Garden
To assess the ovarian reserve, two benchmarks are considered: the number of follicles at 35 and the measurement of anti-Müllerian hormone (AMH). A low AMH level indicates a reduced stock, even if the cycles appear normal. Antral follicles, measuring between 2 and 10 mm, constitute the mobilizable portion during stimulation.
Information from ultrasound and hormonal measurement feeds the dialogue between the patient and the doctor. This approach allows for adjusting monitoring, anticipating certain difficulties, and shedding light on the issue of oocyte quality, which declines in parallel with the number of remaining follicles.
Number of follicles and fertility: what is the reality at this age?
At 35, female fertility faces a biological reality that is hard to ignore: the follicular stock diminishes, and the reserve is no longer what it was at 20. On average, a woman has between 10 and 15 antral follicles detectable by ultrasound at the beginning of the menstrual cycle. However, this number is not a verdict: it fluctuates from person to person and falls within a wide range.
Specialists refer to a low ovarian reserve when the count drops below 5 to 7 follicles. Yet, oocyte quality remains the key factor: even with a low reserve, natural pregnancy is still possible. Doctors also rely on the level of anti-Müllerian hormone (AMH) to refine the diagnosis, taking into account age and the overall context.
The choice of fertility treatment, whether ovarian stimulation or in vitro fertilization, depends on each situation. Cases of ovarian insufficiency or polycystic ovary syndrome (PCOS) require a tailored approach; each cycle tells a different story. The number of follicles at 35 provides a framework for understanding, but never summarizes the complexity of female fertility.
What signs to watch for and when to consult a specialist?
Certain signals deserve attention when it comes to ovarian insufficiency. Irregular cycles that suddenly become shorter or longer raise concerns about the state of the ovaries. A decrease in menstrual flow, the appearance of hot flashes, or sleep disturbances in a 35-year-old woman should prompt vigilance. These manifestations may indicate a decline in ovarian reserve.
Here is a list of situations that warrant special monitoring:
- Family history of early menopause or ovarian diseases
- Signs of polycystic ovary syndrome (PCOS): increased hair growth, persistent acne, unexplained weight gain
- Difficulties in conceiving with regular intercourse for over a year, or six months if the woman is over 35
A medical consultation allows for an antral follicle count, measurement of anti-Müllerian hormone (AMH) levels, and a comprehensive hormonal assessment. These elements guide management and, if necessary, the recourse to ART (assisted reproductive technology) or appropriate fertility treatments.
Staying attuned to the body’s signals and communicating with a specialist gives the best chance to act in time and preserve options for the future. At 35, every decision counts: the follicular stock is not an hourglass that runs out in plain sight, but it serves as a reminder, in its own way, of the need to anticipate.